Guard Therapeutics International AB (publ) - ROE

The ROE as of September 2026 (TTM) for Guard Therapeutics International AB (publ) (GUARD.ST) is -151.94%

According to Guard Therapeutics International AB (publ)’s latest financial reports and current stock price. The company's current ROE is -151.94%. This represents a change of 320.50% compared to the average of -36.13% of the last 4 quarters.

Guard Therapeutics International AB (publ) (GUARD.ST) Historical ROE (quarterly & annually)

How has GUARD.ST ROE performed in the past?

The mean historical ROE of Guard Therapeutics International AB (publ) over the last ten years is 162.90%. The current -151.94% ROE has changed -193.27% with respect to the historical average. Over the past ten years (40 quarters), GUARD.ST's ROE was at its highest in in the December 2018 quarter at 1.37%. The ROE was at its lowest in in the September 2021 quarter at -166.70%.

Guard Therapeutics International AB (publ) (GUARD.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Guard Therapeutics International AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guard Therapeutics International AB (publ) (GUARD.ST) Average ROE

How has GUARD.ST ROE performed in the past?

The current ROE of Guard Therapeutics International AB (publ) (GUARD.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Guard Therapeutics International AB (publ) (GUARD.ST) ROE vs. Peers

How is GUARD.ST’s ROE compared to its peers?

Guard Therapeutics International AB (publ)’s ROE is greater than 2cureX AB (publ) (-30.39%), less than Qlife Holding AB (publ) (987.64%), greater than Aptahem AB (publ) (-8.65%), greater than Modus Therapeutics Holding AB (-177.45%), less than Fluicell AB (publ) (21.37%), greater than Episurf Medical AB (-81.70%), greater than Prostatype Genomics AB (publ) (-229.18%), greater than Stayble Therapeutics AB (publ) (-162.96%), less than ODI Pharma AB (96.44%), greater than Quia Pharma AB (publ) (-96.79%),

Build a custom stock screener for Guard Therapeutics International AB (publ) (GUARD.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guard Therapeutics International AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guard Therapeutics International AB (publ) (GUARD.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guard Therapeutics International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.